ロード中...
Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
Genetic variations along with epigenetic modifications of DNA are involved in colorectal cancer (CRC) development and progression. CRC is the fourth leading cause of cancer-related deaths worldwide. Initiation and progression of CRC is the cumulation of a variety of genetic and epigenetic changes in...
保存先:
| 出版年: | Front Pharmacol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6563763/ https://ncbi.nlm.nih.gov/pubmed/31244652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00588 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|